Capricor Therapeutics Shareholder Alert: Deadline Nears for Lead Plaintiff in Class Action Lawsuit
ClaimsFiler has alerted investors in Capricor Therapeutics that the deadline to apply for lead plaintiff status in a securities class action lawsuit is September 28, 2026.
Investors who incurred losses exceeding $100,000 in Capricor Therapeutics, Inc. securities are reminded of an upcoming deadline to file as lead plaintiff in a class action lawsuit. ClaimsFiler, an investor information service, has set the application deadline for September 28, 2026.
The lawsuit alleges violations of federal securities laws by Capricor Therapeutics. The specific details of the alleged misconduct have not been fully disclosed in the initial alerts.
This action seeks to represent investors who purchased or acquired Capricor Therapeutics stock during a specified period and suffered financial losses as a result of the alleged misrepresentations or omissions.
Interested parties are encouraged to contact ClaimsFiler or their legal counsel to understand the implications of the lawsuit and their potential role as lead plaintiff. Further updates are expected as the case progresses.